Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ironwood Pharmaceuticals Inc (IRWD)  
$8.10 0.21 (2.53%) as of 4:30 Wed 4/24


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 173,744,000
Market Cap: 1.41(B)
Last Volume: 148,509 Avg Vol: 0
52 Week Range: $7.6 - $15.45
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Laboratories & Research

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 8.3
Insider 6 Months    : 8.3
Insider 3/6 Months : 16.7
Guru Rank Number :  607
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focusing on developing the treatment of GI diseases. LINZESS® (linaclotide), Co.'s commercial product, is a product in a class of GI medicines called guanylate cyclase type C agonists and is indicated for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). LINZESS is available to adult men and women suffering from IBS-C or CIC in the U.S. and Mexico and to adult men and women suffering from IBS-C in Japan and China. Co. has partnerships with pharmaceutical companies to support the development and commercialization of linaclotide.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 17,604 17,604 53,676 53,676
Total Buy Value $160,420 $160,420 $460,539 $460,539
Total People Bought 2 2 2 2
Total Buy Transactions 2 2 3 3
Total Shares Sold 280,916 294,129 403,559 1,047,483
Total Sell Value $4,281,159 $4,424,082 $5,556,813 $12,970,668
Total People Sold 5 6 6 9
Total Sell Transactions 5 7 14 48
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 914
  Page 1 of 37  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sarissa Capital Management Lp   –       –       •   2024-03-15 4 A $0.00 $0 D/D 1,662 121,939     -
   Shetzline Michael CMO,SVP,Head-Res&Drug   •       –      –    2024-03-08 4 OE $0.00 $0 D/D 34,936 429,847     -
   Mccourt Thomas A Chief Executive Officer   •       •      –    2024-03-08 4 OE $0.00 $0 D/D 120,298 1,217,948     -
   John Minardo Chief Legal Officer   •       –      –    2024-03-08 4 OE $0.00 $0 D/D 32,752 311,975     -
   Emany Sravan Kumar SVP, Chief Financial Officer   •       –      –    2024-03-08 4 OE $0.00 $0 D/D 37,120 338,853     -
   Davis Andrew SVP, Chief Business Officer   •       –      –    2024-03-08 4 OE $0.00 $0 D/D 37,120 310,756     -
   Duane Jon R   –       •      –    2024-03-06 4 B $8.70 $60,204 D/D 6,920 121,028 0.01 -4%     
   Mccourt Thomas A Chief Executive Officer   •       •      –    2024-03-05 4 A $0.00 $0 D/D 264,876 1,097,650     -
   Emany Sravan Kumar SVP, Chief Financial Officer   •       –      –    2024-03-04 4 B $9.38 $100,216 D/D 10,684 301,733 0.01 -11%     
   Mccourt Thomas A Chief Executive Officer   •       •      –    2024-02-12 4 S $15.24 $2,699,979 D/D (177,164) 832,774 46%     
   Shetzline Michael CMO,SVP,Head-Res&Drug   •       –      –    2024-02-12 4 A $0.00 $0 D/D 54,427 394,911     -
   Shetzline Michael CMO,SVP,Head-Res&Drug   •       –      –    2024-02-12 4 S $15.24 $588,538 D/D (38,618) 340,484 46%     
   John Minardo Chief Legal Officer   •       –      –    2024-02-12 4 A $0.00 $0 D/D 54,427 279,223     -
   John Minardo Chief Legal Officer   •       –      –    2024-02-12 4 S $15.24 $722,071 D/D (47,380) 224,796 46%     
   Emany Sravan Kumar SVP, Chief Financial Officer   •       –      –    2024-02-12 4 A $0.00 $0 D/D 65,312 291,049     -
   Silver Ronald Principal Accounting Officer   •       –      –    2024-02-12 4 A $0.00 $0 D/D 27,213 161,477     -
   Silver Ronald Principal Accounting Officer   •       –      –    2024-02-12 4 S $15.24 $120,518 D/D (7,908) 134,264 46%     
   Davis Andrew SVP, Chief Business Officer   •       –      –    2024-02-12 4 A $0.00 $0 D/D 65,312 273,636     -
   Davis Andrew SVP, Chief Business Officer   •       –      –    2024-02-12 4 S $15.24 $150,053 D/D (9,846) 208,324 46%     
   Emany Sravan Kumar SVP, Chief Financial Officer   •       –      –    2024-02-08 4 D $14.90 $615,847 D/D (41,332) 225,737     -
   Mccourt Thomas A Chief Executive Officer   •       •      –    2024-01-17 4 A $0.00 $0 D/D 249,617 1,009,938     -
   John Minardo Chief Legal Officer   •       –      –    2024-01-17 4 A $0.00 $0 D/D 79,981 272,176     -
   Shetzline Michael CMO,SVP,Head-Res&Drug   •       –      –    2024-01-17 4 A $0.00 $0 D/D 57,971 379,102     -
   Emany Sravan Kumar SVP, Chief Financial Officer   •       –      –    2024-01-17 4 A $0.00 $0 D/D 85,000 267,069     -
   Sarissa Capital Management Lp 10% Owner   –       –       •   2023-12-15 4 A $0.00 $0 D/D 1,347 120,277     -
  914 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 37
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us